Prof. Toni Valković
Sveucilište u Rijeci
H-index: 15
Europe-Croatia
Top articles of Prof. Toni Valković
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 | EClinicalMedicine | Jon Salmanton-García Francesco Marchesi Francesca Farina Barbora Weinbergerová Federico Itri | 2024/5/1 |
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey | Infection | Tobias Lahmer Jon Salmanton-García Francesco Marchesi Shaimaa El-Ashwah Marcio Nucci | 2024/2/22 |
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for … | Biomedicines | Igor Aurer Ozren Jakšić Sandra Bašić-Kinda Stefan Mrđenović Slobodanka Ostojić-Kolonić | 2024/1/31 |
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry | Hematological Oncology | Pellegrino Musto Jon Salmanton‐García Nicola Sgherza Rui Bergantim Francesca Farina | 2024/1 |
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry | Frontiers in immunology | Alessandro Busca Jon Salmanton-García Francesco Marchesi Francesca Farina Guldane Cengiz Seval | 2023/2/24 |
P-258 Carfilzomib in relapsed/refractory multiple myeloma patients–real world evidence: experiences of the Croatian cooperative group for hematologic diseases (KROHEM) | Clinical Lymphoma Myeloma and Leukemia | Davor Galušić Josip Batinić Barbara Dreta Delfa Radić Krišto Mario Piršić | 2023/9/1 |
Anti-Angiogenic Effect of Bortezomib Treatment in Multiple Myeloma is Associated with Lower NF-KB and OPN Expression | JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | Aron Grubesic Toni Valkovic Emina Babarovic Ita Hadzisejdic Luka Vranic | 2023/12/1 |
Primary Nodal Unclassifiable CD20 Negative Diffuse Large B-cell Lymphoma With Dual IgK and TCR Gene Rearrangement: A Diagnostic Challenge | Clinical Pathology | Ita Hadžisejdić Lucia Klarica Emina Babarović Blažen Marijić Toni Valković | 2023/1 |
S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY | HemaSphere | Jon Salmanton-García Francesco Marchesi Maria Gomes Da Silva Francesca Farina Julio Dávila-Valls | 2023/8/1 |
Incidence of Secondary Primary Malignancies after Long-Term Follow up of Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation-Report from Croatian … | Blood | Josip Batinic Barbara Dreta Delfa Radić-Krišto Davor Galusic Jasminka Sinčić Petričević | 2023/12/1 |
A Comparison of Bone Marrow Morphology and Peripheral Blood Findings in Low and High Level JAK2 V617F Allele Burden | Diagnostics | Emina Babarović Blažen Marijić Luka Vranić Josipa Ban Toni Valković | 2023/6/16 |
Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-Lenalidomide-Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the … | Blood | Efstathios Kastritis Meral Beksac Sorina Nicoleta Badelita Eirini Katodritou Jelena Bila | 2023/12/1 |
Dexamethasone Treatment for COVID-19 is Related with Increased Mortality in Haematological Malignancy Patients: Results from the EPICOVIDEHA Registry | Tommaso Francesco Aiello Jon Salmanton-Garcia Francesco Marchesi Barbora Weinbergerova Andreas Glenthoj | 2023/6/13 | |
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings | International Journal of Infectious Diseases | Giuseppe Rossi Jon Salmanton-García Chiara Cattaneo Francesco Marchesi Julio Dávila-Valls | 2023/12/1 |
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry | eClinicalMedicine | Jon Salmanton-García Francesco Marchesi Maria Gomes da Silva Francesca Farina Julio Dávila-Valls | 2023/4/1 |
P-234 Daratumumab in relapsed/refractory multiple myeloma patients–real world evidence–experiences of the Croatian cooperative group for hematologic diseases (KROHEM) | Clinical Lymphoma Myeloma and Leukemia | Josip Batinić Barbara Dreta Davor Galušić Milan Vujčić Marin Šimunić | 2023/9/1 |
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA) | Frontiers in oncology | Maria Stefania Infante Jon Salmanton-García Ana Fernandez-Cruz Francesco Marchesi Ozren Jaksic | 2022/10/4 |
PB2018: MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM RELAPSE IN THE ERA OF NOVEL DRUGS-A MULTICENTER RETROSPECTIVE STUDY FROM THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL … | HemaSphere | Zdravko Mitrovic Josip Batinic D Radic Kristo Ivan Krecak Hrvoje Holik | 2022/6/1 |
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey | Blood advances | Sylvain Lamure Jon Salmanton-García Elena Robin-Marieton Ozren Jaksic Milena Kohn | 2022/7/12 |
Angiogenesis and osteopontin expression in paraskeletal myeloma with plasmablastic morphology and aggressive clinical course: a report of two cases | Journal of Cancer Metastasis and Treatment | Toni Valković Marija Stanić Damić Frane Valković Nives Jonjić | 2022 |
Co-Authors
